Efgartigimod-rituximab sequential therapy in Anti-NMDAR encephalitis: real-world evidence for a novel salvage-maintenance strategy
{{output}}
Background: A subset of anti-NMDAR encephalitis (NMDARe) patients demonstrate suboptimal response to initial immunotherapies (steroids/intravenous immunoglobulin [IVIg]), which poses significant clinical dilemmas regarding therap... ...
